Is it time to tailor treatment on the basis of minimal residual disease in multiple myeloma?

Authors: Stefania Oliva, Martin F Kaiser

Published: 2021-11-24

DOI: 10.1016/s2352-3026(21)00341-0

Source: Full article

Abstract

No abstract found.